(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -72.26%679.54M | ---- | -43.24%2.45B | ---- | 28.18%4.32B | ---- | 56.21%3.37B | ---- | 43.95%2.16B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 5.48%-65.43M | ---- | 39.22%-69.22M | ---- | -21.71%-113.88M | ---- | 9.95%-93.57M | ---- | -234.94%-103.91M |
Dividend (income)- adjustment | ---- | -0.04%-22.81M | ---- | 0.00%-22.8M | ---- | -15.47%-22.8M | ---- | -26.05%-19.75M | ---- | -30.00%-15.67M |
Investment loss (gain) | ---- | ---12.61M | ---- | ---- | ---- | ---- | ---- | 92.81%-418K | ---- | -6.79%-5.82M |
Attributable subsidiary (profit) loss | ---- | 0.00%2K | ---- | 0.00%2K | ---- | 0.00%2K | ---- | -75.00%2K | ---- | -91.40%8K |
Impairment and provisions: | --0 | -47.17%36.39M | --0 | 69.57%68.87M | --0 | 68,942.37%40.62M | --0 | -51.28%-59K | --0 | -101.25%-39K |
-Impairment of trade receivables (reversal) | ---- | -47.17%36.39M | ---- | 69.57%68.87M | ---- | 68,942.37%40.62M | ---- | -51.28%-59K | ---- | 52.44%-39K |
Revaluation surplus: | --0 | 22.80%-2.05B | --0 | -1,918.12%-2.65B | --0 | 121.56%145.82M | --0 | -36.44%-676.21M | --0 | -3.08%-495.61M |
-Fair value of investment properties (increase) | ---- | 19.99%-2.05B | ---- | -1,172.79%-2.57B | ---- | 134.37%239.32M | ---- | -115.29%-696.38M | ---- | 32.39%-323.46M |
-Derivative financial instruments fair value (increase) | ---- | 108.79%7.36M | ---- | 10.51%-83.67M | ---- | -563.59%-93.51M | ---- | 111.71%20.17M | ---- | -7,156.30%-172.19M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --47K |
Asset sale loss (gain): | --0 | 100.65%23K | --0 | 99.91%-3.56M | --0 | -11,926.42%-3.89B | --0 | -1,080.76%-32.38M | --0 | 230.01%3.3M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 99.91%-3.57M | ---- | -11,592.38%-3.89B | ---- | ---33.3M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 187.50%23K | ---- | -11.11%8K | ---- | -99.03%9K | ---- | 46,150.00%925K | ---- | 100.86%2K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 243.06%3.3M |
Depreciation and amortization: | --0 | 6.14%77.95M | --0 | 9.75%73.44M | --0 | 78.92%66.92M | --0 | -7.72%37.4M | --0 | 14.71%40.53M |
-Depreciation | ---- | 6.14%77.95M | ---- | 9.75%73.44M | ---- | 78.92%66.92M | ---- | -7.72%37.4M | ---- | 14.71%40.53M |
Financial expense | ---- | 4.42%1.79B | ---- | 11.60%1.71B | ---- | 22.05%1.53B | ---- | 90.91%1.26B | ---- | 7.24%658M |
Exchange Loss (gain) | ---- | 120.44%31.2M | ---- | 61.03%-152.64M | ---- | -686.70%-391.68M | ---- | 30.17%66.76M | ---- | 157.63%51.29M |
Special items | ---- | --6.98M | ---- | ---- | ---- | 159.46%151.49M | ---- | 185.38%58.39M | ---- | -74.45%20.46M |
Operating profit before the change of operating capital | --0 | -66.44%471.02M | --0 | -23.38%1.4B | --0 | -53.78%1.83B | --0 | 71.72%3.96B | --0 | 43.47%2.31B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 28.16%-74K | ---- | -260.94%-103K | ---- | 158.72%64K | ---- | -121.12%-109K | ---- | 471.22%516K |
Developing property (increase)decrease | ---- | -33.53%-6.47B | ---- | -955.10%-4.84B | ---- | -31.99%-459.09M | ---- | 74.81%-347.81M | ---- | -101.32%-1.38B |
Accounts receivable (increase)decrease | ---- | -39.57%-59.74M | ---- | 42.83%-42.8M | ---- | -293.39%-74.88M | ---- | -105.20%-19.03M | ---- | 201.41%365.76M |
Accounts payable increase (decrease) | ---- | 3.44%3.47B | ---- | 139.01%3.36B | ---- | 173.58%1.4B | ---- | -364.79%-1.91B | ---- | -148.95%-410.61M |
prepayments (increase)decrease | ---- | -46.94%-2.17B | ---- | -319.73%-1.48B | ---- | -587.81%-352.03M | ---- | -42.09%72.17M | ---- | 293.47%124.62M |
Adjustment items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---1.16B | ---- | ---- | ---- | ---- |
Cash from business operations | --0 | -102.48%-3.23B | --0 | -233.49%-1.59B | --0 | -40.21%1.19B | --0 | -39.04%2B | --0 | 145.10%3.28B |
Other taxs | ---- | 28.70%-304.71M | ---- | 37.82%-427.33M | ---- | 19.81%-687.21M | ---- | -64.70%-857.02M | ---- | -379.48%-520.34M |
Special items of business | ---- | 15,174.32%1.53B | ---- | --10.01M | ---- | ---- | ---- | -89.55%236.98M | ---- | --2.27B |
Net cash from operations | -179.45%-4.09B | -74.75%-3.53B | -105.68%-1.46B | -498.73%-2.02B | -503.02%-711.87M | -55.53%506.97M | -88.78%176.64M | -58.62%1.14B | 724.07%1.57B | 124.39%2.76B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -26.10%27.29M | 62.47%78.62M | -16.32%36.93M | -51.48%48.39M | -4.45%44.12M | 52.91%99.72M | 49.84%46.18M | -25.54%65.22M | -69.90%30.82M | 182.35%87.59M |
Dividend received - investment | ---- | ---- | ---- | 0.00%22.8M | ---- | 15.47%22.8M | ---- | 26.05%19.75M | ---- | 30.00%15.67M |
Loan receivable (increase) decrease | 13,225.58%1.72B | -9,200.33%-245.98M | -106.65%-13.1M | 100.24%2.7M | 154.43%196.96M | -58.83%-1.13B | 1,183.59%77.41M | -593.78%-710.9M | -101.59%-7.14M | -168.81%-102.47M |
Decrease in deposits (increase) | -60.60%149.39M | 73.05%1.62B | -63.61%379.15M | 330.71%935.34M | 732.10%1.04B | -136.54%-405.42M | -137.83%-164.81M | 168.74%1.11B | 512.50%435.71M | -100.85%-1.61B |
Sale of fixed assets | ---- | ---- | ---- | 83.92%263K | ---- | 197.92%143K | ---- | -64.44%48K | ---- | -46.43%135K |
Purchase of fixed assets | -121.76%-9.38M | 70.72%-3.17M | -2.05%-4.23M | 31.02%-10.82M | 73.03%-4.14M | 69.95%-15.69M | -482.59%-15.36M | 33.34%-52.2M | 41.81%-2.64M | -918.02%-78.31M |
Sale of subsidiaries | ---- | ---- | ---- | --236K | ---- | ---- | ---- | --25.06M | --25.06M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.81%-1.59B |
Recovery of cash from investments | ---- | -16.17%44.81M | --11.45M | --53.46M | ---- | ---- | ---- | -92.46%32.85M | ---- | -2.43%435.88M |
Cash on investment | -121.24%-438.38M | -484.08%-1.3B | ---198.15M | ---222.19M | ---- | ---- | ---- | 21.63%-246.94M | ---- | 76.83%-315.08M |
Other items in the investment business | ---- | ---- | ---- | ---- | -1,734.19%-36.59M | -95.82%15.32M | -101.00%-2M | 111.24%366.11M | 106.78%198.52M | -1,043.19%-3.26B |
Net cash from investment operations | 583.17%1.45B | -76.50%195.13M | -82.93%212.05M | 158.79%830.18M | 2,220.35%1.24B | -332.13%-1.41B | -108.61%-58.58M | 109.48%608.37M | 129.13%680.33M | -1.32%-6.42B |
Net cash before financing | -111.08%-2.64B | -180.16%-3.34B | -336.14%-1.25B | -31.59%-1.19B | 349.17%530.26M | -151.77%-905.25M | -94.76%118.05M | 147.73%1.75B | 187.15%2.26B | 28.27%-3.66B |
Cash flow from financing activities | ||||||||||
New borrowing | 179.03%11.64B | 32.91%14.45B | -2.12%4.17B | 64.60%10.87B | 16.78%4.26B | -39.22%6.6B | 95.60%3.65B | 31.10%10.86B | -40.12%1.87B | 16.38%8.29B |
Refund | -89.49%-4.79B | -29.82%-10.9B | 38.76%-2.53B | -97.76%-8.4B | -77.97%-4.13B | 48.85%-4.25B | -59.59%-2.32B | -66.20%-8.3B | 34.30%-1.45B | -69.84%-4.99B |
Issuing shares | ---- | ---- | ---- | -91.68%1.21M | 68.80%1.21M | 104.75%14.57M | --718K | -99.59%7.12M | ---- | 183,519.77%1.76B |
Issuance of bonds | ---- | ---- | ---- | -32.88%1.59B | ---- | --2.37B | --1.53B | ---- | ---- | ---- |
Interest paid - financing | -43.59%-1.41B | -10.10%-2.3B | -16.08%-982.61M | -17.50%-2.09B | -6.97%-846.5M | -3.88%-1.78B | -11.14%-791.35M | -38.87%-1.71B | -26.55%-712.05M | -64.01%-1.23B |
Dividends paid - financing | ---- | ---- | ---- | 99.75%-696K | ---- | -20.69%-282.67M | ---- | -15.36%-234.21M | ---- | 3.88%-203.02M |
Absorb investment income | ---- | ---- | ---- | ---- | --165.43M | ---- | ---- | ---- | ---- | --1.39M |
Issuance expenses and redemption of securities expenses | -428.45%-3.17B | 47.52%-1.11B | ---599.31M | -4.79%-2.11B | ---- | -314.29%-2.02B | ---- | ---486.47M | ---- | ---- |
Other items of the financing business | -58.97%-10.18M | 644.91%1.12B | 23.07%-6.4M | 1,057.51%150.15M | -8.71%-8.32M | 63.60%-15.68M | 40.19%-7.66M | 42.83%-43.08M | ---12.8M | ---75.35M |
Net cash from financing operations | 4,002.80%2.26B | 7,108.65%1.26B | 109.95%55.08M | -97.34%17.43M | -126.87%-553.64M | 583.68%656.4M | 759.71%2.06B | -97.29%96.01M | -117.81%-312.3M | -39.59%3.54B |
Effect of rate | -171.68%-11.06M | 150.96%5.23M | 475.31%15.43M | 38.97%-10.27M | 46.14%-4.11M | -189.06%-16.83M | -112.15%-7.63M | 209.74%18.89M | 58.73%-3.6M | -9.34%6.1M |
Net Cash | 67.97%-383.43M | -77.27%-2.08B | -5,020.28%-1.2B | -371.69%-1.17B | -101.07%-23.38M | -113.49%-248.85M | 12.13%2.18B | 1,582.44%1.84B | 332.83%1.94B | -116.56%-124.42M |
Begining period cash | -56.94%1.57B | -24.52%3.65B | -24.52%3.65B | -5.21%4.83B | -5.21%4.83B | 57.66%5.1B | 57.66%5.1B | -3.53%3.23B | -3.53%3.23B | 29.24%3.35B |
Cash at the end | -52.29%1.18B | -56.94%1.57B | -48.69%2.46B | -24.52%3.65B | -33.91%4.8B | -5.21%4.83B | 40.51%7.27B | 57.66%5.1B | 106.25%5.17B | -3.53%3.23B |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data